Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Polymorphisms of Nuclear Factor-κB Family Affect the Bone Mineral Density Response to Zoledronic Acid Therapy in Postmenopausal Chinese Women.

Genes - 27 Jul 2022

Wang Wen-Jie, He Jin-Wei, Fu Wen-Zhen, Wang Chun, Zhang Zhen-Lin

Abstract excerpt

The aim of this study was to explore the allelic association between genetic polymorphisms of the NF-κB pathway and the variance of clinical effects of zoledronic in postmenopausal Chinese women with osteoporosis. In the study, 110 Chinese postmenopausal women with osteoporosis were recruited. Every patient received zoledronic once a year. BMD was measured at baseline and after one year of treatment. The 13...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Density
Share to China
Share to NF-kappa B

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Osteoporosis

Share to Polymorphism, Single Nucleotide

Share to Postmenopause

Source

Open in PubMed Open full text

Identifiers

PMID: 36011257
DOI: 10.3390/genes13081343
PMCID: PMC9407517

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Polymorphisms of Nuclear Factor-κB Family Affect the Bone Mineral Density Response to Zoledronic Acid Therapy in Postmenopausal Chinese Women.PMID 36011257Read ↗

Genetic polymorphisms in the mevalonate pathway affect the therapeutic response to alendronate treatment in postmenopausal Chinese women with low bone mineral density.Semantic proximity Read ↗

Polymorphisms in genes in the RANKL/RANK/OPG pathway are associated with bone mineral density at different skeletal sites in post-menopausal women.Semantic proximity Read ↗

OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia.Semantic proximity Read ↗

Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women.Semantic proximity Read ↗

The association between polymorphisms in Wnt antagonist genes and bone response to hormone therapy in postmenopausal Korean women.Semantic proximity Read ↗

Association between polymorphisms in Wnt signaling pathway genes and bone mineral density in postmenopausal Korean women.Semantic proximity Read ↗

Replication Study Confirms the Association of the Common rs1800629 Variant of the TNFα Gene with Postmenopausal Osteoporosis Susceptibility in the Han Chinese Population.Semantic proximity Read ↗

Polymorphisms in genes involved in the NF-κB signalling pathway are associated with bone mineral density, geometry and turnover in men.Semantic proximity Read ↗

Association of a promoter haplotype (-1542G/-525C) in the tumor necrosis factor receptor associated factor-interacting protein gene with low bone mineral density in Japanese women.Semantic proximity Read ↗

Genetic polymorphisms in IL1B predict susceptibility to steroid-induced osteonecrosis of the femoral head in Chinese Han populationSemantic proximity Read ↗

TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.Semantic proximity Read ↗

Cannabinoid receptor gene polymorphisms and bone mineral density in Korean postmenopausal women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.